Showing results (671-680 of 5,268) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|May 31, 2001
Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapyO Sezer, K Niemöller, O Kaufmann, et al.
European Journal of Haematology|May 31, 2001
Decreased amount of mpl and reduced expression of glycoprotein IIb/IIIa and glycoprotein Ib on platelets from patients with refractory anemia: analysis by a non-isotopic quantitative ligand binding assay and immunofluorescenceM Izumi, A Takeshita, K Shinjo, et al.
European Journal of Haematology|February 13, 2001
Effects of sympathetic activation by adrenergic infusions on hemostasis in vivoR von Känel, J E Dimsdale
European Journal of Haematology|February 13, 2001
HPA-1a-mediated platelet interaction with monocytes in vitro: involvement of Fcgamma receptor (FcgammaR) classes and inhibition by humanised monoclonal anti-FcgammaRI H22E Wiener, F Mawas, P Coates, et al.
European Journal of Haematology|February 13, 2001
Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemiaE C Hatzimichael, L Christou, M Bai, et al.
European Journal of Haematology|February 13, 2001
Unexpectedly high incidence of hypoplastic/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxyadenosine therapyS Gillis, G Amir, M Bennett, et al.
European Journal of Haematology|February 13, 2001
Multiple myeloma in elderly patients: presenting features and outcomeP Rodon, C Linassier, J B Gauvain, et al.
European Journal of Haematology|February 13, 2001
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study GroupK Zervas, A Pouli, B Gregoraki, et al.
European Journal of Haematology|February 13, 2001
Allogeneic or autologous stem cell transplantation (SCT) for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma: a single-centre experienceD Nachbaur, W Oberaigner, E Fritsch, et al.
European Journal of Haematology|February 13, 2001
Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: a new entity?T Lavabre-Bertrand, P Bourquard, J Chiesa, et al.
Pageof 527